" class="no-js "lang="en-US"> OncoHost - Medtech Alert
Friday, March 29, 2024
OncoHost | Pharmtech Focus

OncoHost

About OncoHost

OncoHost

OncoHost develops personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, we aim to understand the patient’s unique response to therapy and overcome one of the major obstacles in clinical oncology today – resistance to therapy. Based on robust scientific infrastructure and a strong IP position, OncoHost is launching an extensive clinical program with leading academic and clinical partners.

Related Story

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

June 14 2022

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a […]